Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors.

D.A. HABER , D.W. BELL , R. SORDELLA , E.L. KWAK
Cold Spring Harbor Symposia on Quantitative Biology 70 419 -426

138
2005
Hereditary breast cancer.

Leif W. Ellisen, MD, PhD , Daniel A. Haber, MD, PhD
Annual Review of Medicine 49 ( 1) 425 -436

68
1998
Methods relating to circulating tumor cell clusters and the treatment of cancer

Nicola Aceto , Daniel Arie HABER , Shyamala Maheswaran

2015
MULTIDRUG RESISTANCE (MDR1) IN ACUTE MYELOGENOUS LEUKEMIA: IS IT TIME TO TEST? REPLY

M BACCARNI , M MICHIELI , D DAMIANI , A MICHELUTTI
Blood 80 ( 4) 1094 -1095

1992
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers

Anurag Singh , Michael F. Sweeney , Min Yu , Alexa Burger
Cell 148 ( 4) 639 -650

215
2012
The evolving war on cancer.

Daniel A. Haber , Nathanael S. Gray , Jose Baselga
Cell 145 ( 1) 19 -24

178
2011
The WTX Tumor Suppressor Regulates Mesenchymal Progenitor Cell Fate Specification

Annie Moisan , Miguel N. Rivera , Sutada Lotinun , Sara Akhavanfard
Developmental Cell 20 ( 5) 583 -596

42
2011
The WTX tumor suppressor enhances p53 acetylation by CBP/p300.

Woo Jae Kim , Miguel N. Rivera , Erik J. Coffman , Daniel A. Haber
Molecular Cell 45 ( 5) 587 -597

51
2012
Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells

David T. Ting , Ben S. Wittner , Matteo Ligorio , Nicole Vincent Jordan
Cell Reports 8 ( 6) 1905 -1918

443
2014
Dynamic Chromatin Modification Sustains Epithelial-Mesenchymal Transition following Inducible Expression of Snail-1

Sarah Javaid , Jianmin Zhang , Endre Anderssen , Josh C. Black
Cell Reports 5 ( 6) 1679 -1689

69
2013
Isolation and Molecular Characterization of Circulating Melanoma Cells

Xi Luo , Devarati Mitra , Ryan J. Sullivan , Ben S. Wittner
Cell Reports 7 ( 3) 645 -653

69
2014
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis

Nicola Aceto , Aditya Bardia , David T. Miyamoto , Maria C. Donaldson
Cell 158 ( 5) 1110 -1122

2,121
2014
Induction of p21 by the Wilms' Tumor Suppressor Gene WT1

D A Haber , S Maheswaran , C Englert , J Kreidberg
Cancer Research 57 ( 8) 1429 -1434

111
1997
Role of the WT1 gene in Wilms' tumour.

D A Haber , D E Housman
Cancer surveys 12 105 -117

30
1992
The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.

S Maheswaran , C Englert , P Bennett , G Heinrich
Genes & Development 9 ( 17) 2143 -2156

229
1995
Expression of the Wilms' tumor gene WT1 in the murine urogenital system.

J Pelletier , M Schalling , A J Buckler , A Rogers
Genes & Development 5 ( 8) 1345 -1356

388
1991
In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2

S Kim , G Mohapatra , D A Haber
British Journal of Cancer 99 ( 8) 1302 -1306

2008
Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development.

A J Buckler , J Pelletier , D A Haber , T Glaser
Molecular and Cellular Biology 11 ( 3) 1707 -1712

233
1991
A Novel Repressor, par-4, Modulates Transcription and Growth Suppression Functions of the Wilms' Tumor Suppressor WT1

R W Johnstone , R H See , S F Sells , J Wang
Molecular and Cellular Biology 16 ( 12) 6945 -6956

217
1996
Primary gastrointestinal lymphoma.

Haber Da , Mayer Rj
Seminars in Oncology 15 ( 2) 154

67
1988